Systemic arteriosclerosis and eating behavior in Japanese type 2 diabetic patients with visceral fat accumulation
暂无分享,去创建一个
T. Funahashi | I. Shimomura | S. Fukuda | A. Imagawa | T. Yasuda | H. Nishizawa | N. Maeda | Y. Fujishima | J. Kozawa | Masaya Yamaoka | Susumu Kashine | A. Hirata | Tetsuhiro Kitamura | H. Nagao | Kana Inoue | T. Kimura
[1] F. Gao,et al. A reduction in both visceral and subcutaneous fats contributes to increased adiponectin by lifestyle intervention in the Diabetes Prevention Program , 2015, Acta Diabetologica.
[2] F. Hu,et al. Circulating adiponectin and cardiovascular mortality in patients with type 2 diabetes mellitus: evidence of sexual dimorphism , 2014, Cardiovascular Diabetology.
[3] A. Tenenbaum,et al. Adiponectin: a manifold therapeutic target for metabolic syndrome, diabetes, and coronary disease? , 2014, Cardiovascular Diabetology.
[4] F. Farzadfar,et al. Predictive factors of diabetic complications: a possible link between family history of diabetes and diabetic retinopathy , 2014, Journal of Diabetes & Metabolic Disorders.
[5] T. Funahashi,et al. Vascular complications and changes in body mass index in Japanese type 2 diabetic patients with abdominal obesity , 2013, Cardiovascular Diabetology.
[6] Y. Matsuzawa,et al. Serum adiponectin levels predict the risk of coronary heart disease in Japanese patients with type 2 diabetes , 2013, Journal of diabetes investigation.
[7] C. Takayama,et al. Brown Rice and Its Component, γ-Oryzanol, Attenuate the Preference for High-Fat Diet by Decreasing Hypothalamic Endoplasmic Reticulum Stress in Mice , 2012, Diabetes.
[8] T. Funahashi,et al. Efficacy of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight, eating behavior, and glycemic control, in Japanese obese type 2 diabetes , 2012, Cardiovascular Diabetology.
[9] T. Funahashi,et al. Metabolic syndrome correlates with polyvascular lesions detected by systemic vascular ultrasonography in Japanese people with type 2 diabetes. , 2012, Diabetes research and clinical practice.
[10] T. Funahashi,et al. Cardio Vascular Diabetology O R I G I N a L I N V E S T I G a T I O N Open Access , 2022 .
[11] T. Funahashi,et al. Qualitative score of systemic arteriosclerosis by vascular ultrasonography as a predictor of coronary artery disease in type 2 diabetes. , 2011, Atherosclerosis.
[12] T. Wong,et al. Are obesity and anthropometry risk factors for diabetic retinopathy? The diabetes management project. , 2011, Investigative ophthalmology & visual science.
[13] P. Whincup,et al. High adiponectin and increased risk of cardiovascular disease and mortality in asymptomatic older men: does NT-proBNP help to explain this association? , 2011, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[14] S. Kihara,et al. Increment and impairment of adiponectin in renal failure. , 2010, Cardiovascular research.
[15] C. Snehalatha,et al. Diabetes in Asia , 2010, The Lancet.
[16] Yasuhiko Tomino,et al. Revised equations for estimated GFR from serum creatinine in Japan. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[17] Weiping Jia,et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. , 2009, JAMA.
[18] H. Kaneto,et al. Serum endogenous secretory RAGE level is an independent risk factor for the progression of carotid atherosclerosis in type 1 diabetes. , 2009, Atherosclerosis.
[19] Margarita D. Tsiros,et al. Cognitive behavioral therapy improves diet and body composition in overweight and obese adolescents. , 2008, The American journal of clinical nutrition.
[20] 岡内 幸義. Reduction of Visceral Fat Is Associated With Decrease in the Number of Metabolic Risk Factors in Japanese Men , 2008 .
[21] P Zimmet,et al. Ethnic comparisons of the cross‐sectional relationships between measures of body size with diabetes and hypertension , 2008, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[22] J. Holst. The physiology of glucagon-like peptide 1. , 2007, Physiological reviews.
[23] Ho-Young Son,et al. Epidemic obesity and type 2 diabetes in Asia , 2006, The Lancet.
[24] Makoto Nishida,et al. A new simple method for the measurement of visceral fat accumulation by bioelectrical impedance. , 2005, Diabetes care.
[25] Nader Rifai,et al. Plasma adiponectin levels and risk of myocardial infarction in men. , 2004, JAMA.
[26] S. Kihara,et al. Adiponectin Reduces Atherosclerosis in Apolipoprotein E-Deficient Mice , 2002, Circulation.
[27] S. Kihara,et al. Adipocyte-Derived Plasma Protein Adiponectin Acts as a Platelet-Derived Growth Factor-BB–Binding Protein and Regulates Growth Factor–Induced Common Postreceptor Signal in Vascular Smooth Muscle Cell , 2002, Circulation.
[28] R. Roubenoff,et al. Eating behavior correlates of adult weight gain and obesity in healthy women aged 55-65 y. , 2002, The American journal of clinical nutrition.
[29] Y. Akanuma,et al. Risk factors for the development of diabetic retinopathy in Japanese type 2 diabetic patients. , 2001, Diabetes research and clinical practice.
[30] S. Kihara,et al. Adipocyte-Derived Plasma Protein, Adiponectin, Suppresses Lipid Accumulation and Class A Scavenger Receptor Expression in Human Monocyte-Derived Macrophages , 2001, Circulation.
[31] T Nakamura,et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[32] T Nakamura,et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. , 1999, Circulation.
[33] T Nakamura,et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. , 1999, Biochemical and biophysical research communications.
[34] R. Holman,et al. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .
[35] Uk-Prospective-Diabetes-Study-Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) , 1998, The Lancet.
[36] T. Funahashi,et al. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). , 1996, Biochemical and biophysical research communications.
[37] S. Genuth,et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.
[38] J. Després,et al. Effects of Diet and Physical Activity on Adiposity and Body Fat Distribution: Implications for the Prevention of Cardiovascular Disease , 1993, Nutrition Research Reviews.
[39] E. Buskirk,et al. Ventilatory response of moderately obese women to submaximal exercise. , 1991, International journal of obesity.
[40] T. Funahashi,et al. Relationships between circulating adiponectin levels and fat distribution in obese subjects. , 2011, Journal of atherosclerosis and thrombosis.
[41] P. Barnes,et al. Epidemiology, Risk Factors and Pathophysiology , 2011 .
[42] J. Shaw,et al. Global estimates of the prevalence of diabetes for 2010 and 2030. , 2010, Diabetes research and clinical practice.
[43] E. Oda. New criteria for 'obesity disease' in Japan. , 2006, Circulation journal : official journal of the Japanese Circulation Society.
[44] H. Minuk,et al. Metabolic syndrome. , 2005, Journal of insurance medicine.
[45] Eiji Oda,et al. New criteria for 'obesity disease' in Japan. , 2002, Circulation journal : official journal of the Japanese Circulation Society.
[46] Y. Matsuzawa,et al. Treatment of visceral fat obesity. , 1991, International journal of obesity.
[47] S. Colagiuri,et al. The Diabetes Control and Complications Trial , 1983, Henry Ford Hospital medical journal.